This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its trifluoromethyl group enhances the biological activity and metabolic stability of the resulting drugs, making it valuable in the development of compounds targeting central nervous system disorders, such as depression and anxiety. Additionally, it is employed in the creation of small molecule inhibitors for enzymes or receptors involved in inflammatory and autoimmune diseases. Its structural features also make it a candidate for research in drug discovery programs focused on optimizing pharmacokinetic properties.